BioMarin to Attend Two Upcoming Investor Conferences

SAN RAFAEL, Calif., May 2, 2017 /PRNewswire/ -- BioMarin Pharmaceutical Inc. BMRN, today announced that Jean-Jacques Bienaimé, Chairman and Chief Executive Officer, will participate in Deutsche Bank's 42^nd Annual Health Care Conference on May 3, 2017 at 9:20am ET, in Boston and the Bank of America Merrill Lynch 2017 Health Care Conference on May 16, 2017 at 1:40pm PT/4:40pm ET, in Las Vegas.  To access the live webcasts, please visit the investor section of the BioMarin website, www.biomarin.com. A replay will also be archived on the site for at least one week following each event.

About BioMarin

BioMarin is a global biotechnology company that develops and commercializes innovative therapies for people with serious and life-threatening rare disorders. The company's portfolio consists of six commercialized products and multiple clinical and pre-clinical product candidates.  

For additional information, please visit www.biomarin.com. Information on BioMarin's website is not incorporated by reference into this press release.

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/biomarin-to-attend-two-upcoming-investor-conferences-300449079.html

SOURCE BioMarin Pharmaceutical Inc.